Neuroprosthesis serves as communication aid for ALS patient for 7 years

A neuroprosthesis enabled an ALS patient to communicate independently for seven years, showing the long-term potential of brain-computer interfaces.
In 2015, a team at UMC Utrecht treated a woman with ALS by implanting a neuroprosthesis to help her communicate. Now, in a new publication, the Utrecht team shows for the first time that this neuroprosthesis was successfully used independently at home over a period of seven years. It served as the participant’s primary communication tool and became fully integrated into her daily life. This demonstrates that neuroprostheses can enable patients to communicate more effectively and maintain control over their lives for a longer time, until the disease progresses to a point where even the prosthesis can no longer provide support.
The results of the research, lead by Mariska van Steensel and Nick Ramsey, can be found in the New England Journal of Medicine.
ALS is een progressieve spierziekte
People with ALS face a poor prognosis. The disease progressively affects more muscles, eventually making movement, communication, and ultimately life itself impossible. In the final stage, a patient may develop Locked-In Syndrome, in which no form of communication is possible anymore.
The neuroprosthesis as a solution
To compensate for the progressive decline, researchers at UMC Utrecht are working on the development of neuroprostheses, also known as Brain-Computer Interfaces (BCIs). A neuroprosthesis consists of electrodes implanted in the brain that pick up signals. These signals are then translated via a computer connection into commands for operating a computer, such as a mouse click. This enables a patient to continue communicating even after the onset of Locked-In Syndrome.
How long does a neuroprosthesis work?
For the first time, the UMC Utrecht team conducted a long-term study on an ALS patient who received a neuroprosthesis. The study showed promising results. Mariska: “Our participant used the system independently for seven years, and for several of those years it was her only way of alerting her caregiver, both during the day and at night.” The device itself continued functioning well. Only when the disease had progressed to the point that the brain could no longer send strong signals did the neuroprosthesis stop being effective.
While the disease cannot be halted with a neuroprosthesis, the technology can still make a crucial difference in the quality of life and autonomy of people with ALS, even in later stages. “As long as the brain is able to send a message, the system works—and it can make a tremendous difference in the lives of these patients and their families,” says Mariska.
Neuroprostheses are becoming more accessible
The development of neuroprostheses is advancing rapidly, with significant investment being made. It is expected that in the coming years, these devices will become widely available and can be used to help people with severe communication impairments caused by ALS or other conditions. This is also reflected in the current edition of the New England Journal of Medicine, which features a second article on BCIs. “In that other study, a person in an earlier stage of ALS was able to communicate quickly and accurately using a BCI. This shows that BCIs can also be valuable for people with less severe impairments.”
Furthermore, (new) treatments that slow the progression of ALS are likely to extend the period in which a BCI can be useful.
“We are currently working on improved versions of the technology and hope to demonstrate its value as a communication tool in the daily lives of these patients in our new projects: CORTICOM, INTENSE, and INTRECOM,” Mariska concludes.
Source: UMC Utrecht

Utrecht Science Park Summer Café: Farewell to Managing Director Jan Henk van der Velden
On Monday, 6 July, the Utrecht Science Park Summer Café took place at Grand Café Living on Utrecht Science Park. This edition was dedicated to the farewell of Jan Henk van der Velden, Managing Director of the Utrecht Science Park Foundation, after nine years in which he played a key role in the development and positioning of the ecosystem.

Petra Baarendse appointed new Managing Director of Stichting Utrecht Science Park as of 1 September
Utrecht, 2 July 2026 – As of 1 September 2026, Petra Baarendse will take office as the new Managing Director of Stichting Utrecht Science Park. She succeeds Jan Henk van der Velden, who has stepped down and will take on a new role as Managing Director of Stichting Nationaal Park Utrechtse Heuvelrug.

Registration for Utrecht Science Week 2026 is now open: the knowledge festival at Utrecht Science Park
From Friday 25 September to Sunday 4 October, the sixth edition of Utrecht Science Week will take place. Utrecht Science Park will open its doors to everyone interested in (applied) science and innovation in the fields of life sciences, health, and sustainability.
The first programme elements have now been announced and registration is open. Many more events and activities will be added to the programme in the coming weeks.

Opening Utrecht Science Week with keynote by Juliette Legler on the hidden influence of environmental chemicals
On Friday, September 25, the annual science festival ‘Utrecht Science Week’ kicks off once again at Utrecht Science Park. We are pleased to announce that this year, Prof. Dr. Ir. Juliette Legler will deliver the Utrecht Science Lecture. Juliette Legler is Professor of Toxicology at the Faculty of Veterinary Medicine at Utrecht University and leads the ‘One Health Toxicology’ group at the Institute for Risk Assessment Sciences (IRAS).